Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

November 01, 2005; Volume 32,Issue 11
  • You have access
    Adding nails to the coffin of underpowered trials.
    Scott D Halpern
    The Journal of Rheumatology November 1 2005, 32 (11) 2065-2066;
  • You have access
    Discovering that B cells are important in rheumatoid arthritis.
    R John Looney
    The Journal of Rheumatology November 1 2005, 32 (11) 2067-2069;
  • You have access
    Can magnetic resonance imaging of the knee predict future malalignment?
    Khalid A Syed and Nizar N Mahomed
    The Journal of Rheumatology November 1 2005, 32 (11) 2070-2071;
  • You have access
    Bones, blood vessels, and the immune system: what's the link?
    Rae S M Yeung
    The Journal of Rheumatology November 1 2005, 32 (11) 2072-2074;
  • You have access
    Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty?
    Coen A Stegeman
    The Journal of Rheumatology November 1 2005, 32 (11) 2075-2077;
  • You have access
    Treatment of hepatitis C virus-related systemic vasculitis.
    Patrice Cacoub, David Saadoun, Damien Sene, Nicolas Limal and Jean-Charles Piette
    The Journal of Rheumatology November 1 2005, 32 (11) 2078-2082;
  • You have access
    The prevalence of underpowered randomized clinical trials in rheumatology.
    Helen I Keen, Kevin Pile and Catherine L Hill
    The Journal of Rheumatology November 1 2005, 32 (11) 2083-2088;
  • You have access
    The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.
    Susanna Sihvonen, Markku Korpela, Anu Mustila and Jukka Mustonen
    The Journal of Rheumatology November 1 2005, 32 (11) 2089-2094;
  • You have access
    Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
    Canan Tikiz, Ozan Utuk, Timur Pirildar, Ozgur Bayturan, Petek Bayindir, Fatma Taneli, Hakan Tikiz and Cigdem Tuzun
    The Journal of Rheumatology November 1 2005, 32 (11) 2095-2101;
  • You have access
    Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
    Inmaculada Macías, Sergio García-Pérez, Mar Ruiz-Tudela, Fermín Medina, Nicolás Chozas and José A Girón-González
    The Journal of Rheumatology November 1 2005, 32 (11) 2102-2108;
  • You have access
    Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Jean Higashida, Ted Wun, Sara Schmidt, Stanley M Naguwa and Joseph M Tuscano
    The Journal of Rheumatology November 1 2005, 32 (11) 2109-2115;
  • You have access
    Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis.
    John C Mavropoulos, Miguel Cuchacovich, Carolina Llanos, Juan C Aguillón, Hector Gatica, Salvatore V Pizzo and Mario Gonzalez-Gronow
    The Journal of Rheumatology November 1 2005, 32 (11) 2116-2124;
  • You have access
    Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment.
    Stefano Bassetti, Sarah Wasmer, Paul Hasler, Thomas Vogt, Danica Nogarth, Reno Frei and Andreas F Widmer
    The Journal of Rheumatology November 1 2005, 32 (11) 2125-2129;
  • You have access
    Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
    Eliza F Chakravarty, Kaleb Michaud and Frederick Wolfe
    The Journal of Rheumatology November 1 2005, 32 (11) 2130-2135;
  • You have access
    Static wrist splint use in the performance of daily activities by individuals with rheumatoid arthritis.
    Ada Pagnotta, Nicol Korner-Bitensky, Barbara Mazer, Murray Baron and Sharon Wood-Dauphinee
    The Journal of Rheumatology November 1 2005, 32 (11) 2136-2143;
  • You have access
    The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern.
    Alessandra Dellavance, Vilma S T Viana, Elaine P Leon, Eloisa S D O Bonfa, Luís E C Andrade and Paulo G Leser
    The Journal of Rheumatology November 1 2005, 32 (11) 2144-2149;
  • You have access
    Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.
    Luis M Vilá, Graciela S Alarcón, Gerald McGwin Jr, Holly M Bastian, Barri J Fessler, John D Reveille and LUMINA Study Group
    The Journal of Rheumatology November 1 2005, 32 (11) 2150-2155;
  • You have access
    Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
    Masaya Kobayashi, Seiji Kawano, Saori Hatachi, Chiyo Kurimoto, Taku Okazaki, Yoshiko Iwai, Tasuku Honjo, Yoshimasa Tanaka, Nagahiro Minato, Takahide Komori, Sakan Maeda and Shunichi Kumagai
    The Journal of Rheumatology November 1 2005, 32 (11) 2156-2163;
  • You have access
    Serum relaxin in systemic sclerosis.
    Nicola Giordano, Panayotis Papakostas, Barbara Lucani, Alessandra Amendola, Fiorenza Cipolli, Vita Maria Agate, Emilio Battisti, Giuseppe Martini and Ranuccio Nuti
    The Journal of Rheumatology November 1 2005, 32 (11) 2164-2166;
  • You have access
    Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
    Floriana Lurati-Ruiz and François Spertini
    The Journal of Rheumatology November 1 2005, 32 (11) 2167-2172;
  • You have access
    Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis.
    Carlo Salvarani, Bruno Casali, Enrico Farnetti, Nicolò Pipitone, Davide Nicoli, Pierluigi Macchioni, Luca Cimino, Gianluigi Bajocchi, Maria Grazia Catanoso and Luigi Boiardi
    The Journal of Rheumatology November 1 2005, 32 (11) 2173-2177;
  • You have access
    Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
    Miguel A Gonzalez-Gay, Javier Oliver, Elena Sanchez, Carlos Garcia-Porrua, Laura Paco, Miguel A Lopez-Nevot, William E R Ollier and Javier Martin
    The Journal of Rheumatology November 1 2005, 32 (11) 2178-2182;
  • You have access
    Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
    Caroline Delaunay, Valérie Farrenq, André Marini-Portugal, Jean-David Cohen, Xavier Chevalier and Pascal Claudepierre
    The Journal of Rheumatology November 1 2005, 32 (11) 2183-2185;
  • You have access
    Female gout: clinical and laboratory features.
    Alexandre W S De Souza, Vander Fernandes and Antônio J L Ferrari
    The Journal of Rheumatology November 1 2005, 32 (11) 2186-2188;
  • You have access
    Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed?
    José Alvarez-Nemegyei, Martha Medina-Escobedo, Salha Villanueva-Jorge and Janitzia Vazquez-Mellado
    The Journal of Rheumatology November 1 2005, 32 (11) 2189-2191;
  • You have access
    Structural factors associated with malalignment in knee osteoarthritis: the Boston osteoarthritis knee study.
    David J Hunter, Yuqing Zhang, Jingbo Niu, Xianghua Tu, Shreyasee Amin, Joyce Goggins, Michael Lavalley, Ali Guermazi, Daniel Gale and David T Felson
    The Journal of Rheumatology November 1 2005, 32 (11) 2192-2199;
  • You have access
    Relationship between bone markers and knee cartilage volume in healthy men.
    Yuanyuan Wang, Peter R Ebeling, Fahad Hanna, Richard O'Sullivan and Flavia M Cicuttini
    The Journal of Rheumatology November 1 2005, 32 (11) 2200-2204;
  • You have access
    Increased monocyte chemoattractant protein-1 in knee joints of rats with adjuvant-induced arthritis: in vivo microdialysis.
    Shao-Hsiang Liu, Chih-Shung Wong and Deh-Ming Chang
    The Journal of Rheumatology November 1 2005, 32 (11) 2205-2211;
  • You have access
    Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
    Nigel L Ashworth, Paul M Peloso, Nazeem Muhajarine and Maryrose Stang
    The Journal of Rheumatology November 1 2005, 32 (11) 2212-2217;
  • You have access
    Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.
    C Mel Wilcox, Byron Cryer and George Triadafilopoulos
    The Journal of Rheumatology November 1 2005, 32 (11) 2218-2224;
  • You have access
    Primary Sjögren's syndrome in children and adolescents: are proposed diagnostic criteria applicable?
    Kristin Houghton, Peter Malleson, David Cabral, Ross Petty and Lori Tucker
    The Journal of Rheumatology November 1 2005, 32 (11) 2225-2232;
  • You have access
    Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Gabriele Simonini, Laura Masi, Teresa Giani, Elisabetta Piscitelli, Rolando Cimaz, Silvia Vierucci, Maria Luisa Brandi and Fernanda Falcini
    The Journal of Rheumatology November 1 2005, 32 (11) 2233-2238;
  • You have access
    Magnetic resonance imaging in pachydermodactyly.
    Ananthila Anandacoomarasamy, Hae-Sung Bak, Anthony Peduto and Nicholas Manolios
    The Journal of Rheumatology November 1 2005, 32 (11) 2239-2241;
  • You have access
    Lymphomatoid granulomatosis: a rare mimicker of vasculitis.
    Sherry M Wu, Yoon Min, Nora Ostrzega, Philip J Clements and Andrew L Wong
    The Journal of Rheumatology November 1 2005, 32 (11) 2242-2245;
  • You have access
    Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.
    John R Kirwan, Monica Ahlmén, Maarten de Wit, Turid Heiberg, Maggie Hehir, Sarah Hewlett, Patricia P Katz, Patricia Minnock, Enid M Quest and Pam Richards
    The Journal of Rheumatology November 1 2005, 32 (11) 2246-2249;
  • You have access
    Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.
    John R Kirwan, Sarah E Hewlett, Turid Heiberg, Rod A Hughes, Maggie Carr, Maggie Hehir, Tore K Kvien, Patricia Minnock, Stanton P Newman, Enid M Quest, Erik Taal and Janney Wale
    The Journal of Rheumatology November 1 2005, 32 (11) 2250-2256;
  • You have access
    Attributes and skills of an effective musculoskeletal consumer.
    Peter S Tugwell, Andrew J Wilson, Peter M Brooks, S Michelle Driedger, Cindy Gallois, Annette M O'Connor, Ann Qualman, Nancy Santesso, Janet Wale and George A Wells
    The Journal of Rheumatology November 1 2005, 32 (11) 2257-2261;
  • You have access
    Outcome measures in psoriatic arthritis.
    Dafna D Gladman, Philip J Mease, Gerald Krueger, Désirée M F M van der Heidje, Christian Antoni, Philip S Helliwell, Arthur F Kavanaugh, Peter Nash, Christopher T Ritchlin, C Vibeke Strand and William Taylor
    The Journal of Rheumatology November 1 2005, 32 (11) 2262-2269;
  • You have access
    Fibromyalgia syndrome.
    Philip J Mease, Daniel J Clauw, Lesley M Arnold, Don L Goldenberg, James Witter, David A Williams, Lee S Simon, C Vibeke Strand, Candace Bramson, Susan Martin, Timothy M Wright, Bruce Littman, J F Wernicke, R Michael Gendreau and Leslie J Crofford
    The Journal of Rheumatology November 1 2005, 32 (11) 2270-2277;
  • You have access
    Can hand assessments designed for persons with scleroderma be valid for persons with rheumatoid arthritis?
    Janet L Poole and Kenneth J Cordova
    The Journal of Rheumatology November 1 2005, 32 (11) 2278-2280;
  • You have access
    The arthritis of familial Mediterranean fever.
    Imad Uthman
    The Journal of Rheumatology November 1 2005, 32 (11) 2278;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 32, Issue 11
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Extravascular Necrotizing Granuloma: A Diagnostic Clue for Eosinophilic Granulomatosis With Polyangiitis
  • Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series
  • Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines
  • Melorheostosis or “Dripping Candle Wax” Bone Disease
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire